Reaction
Retinal Vascular Disorder reporting signals
As of the last recalculation, Retinal Vascular Disorder appears in 568 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 111.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 71 | 111.9 | 112.2 |
| Quinine | 22 | 97.8 | 98.0 |
| Aflibercept | 40 | 50.5 | 50.5 |
| Faricimab | 8 | 36.7 | 36.7 |